Format

Send to

Choose Destination
J Cardiovasc Pharmacol. 2008 Oct;52(4):293-9. doi: 10.1097/FJC.0b013e318171924d.

Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics.

Author information

1
Department of Pharmacology and Toxicology, Dresden University of Technology, Dresden, Germany. dobrev@rcs.urz.tu-dresden.de

Abstract

Atrial electrical and structural alterations (remodeling) have emerged as key elements in the development of the atrial fibrillation (AF) substrate. Evidence points to abnormalities in intracellular Ca (calcium) handling as crucial links in AF-initiating focal activity and in perpetuation by rapidly firing foci and reentry. This review focuses on the molecular basis of altered Ca handling in AF, with the goal of providing new insights into molecular effective antiarrhythmic therapy.

PMID:
18791467
DOI:
10.1097/FJC.0b013e318171924d
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center